Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Gambogic acid-loaded PEG–PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Zhang, Dinghu1 (AUTHOR); Zou, Zhengyun2 (AUTHOR); Ren, Wei2 (AUTHOR); Qian, Hanqing2 (AUTHOR); Cheng, Qianfeng2 (AUTHOR); Ji, Liulian1 (AUTHOR); Liu, Baorui1,2 (AUTHOR); Liu, Qin2 (AUTHOR)
- Source:
Pharmaceutical Development & Technology. Jan2018, Vol. 23 Issue 1, p33-40. 8p.
- Subject Terms:
- Additional Information
- Abstract:
Poor water solubility and side effects hampered the clinical application of gambogic acid (GA) in cancer therapy. Accordingly, GA-loaded polyethylene glycol-poly(ɛ-caprolactone) (PEG–PCL) nanoparticles (GA-NPs) were developed and administered peritumorally to evaluate their antitumor activity. The particle size, polydispersity index, encapsulation efficiency and loading capacity of GA-NPs were 143.78 ± 0.054 nm, 0.179 ± 0.004, 81.3 ± 2.5% and 14.8 ± 0.6%, respectively. In addition, GA-NPs showed excellent stability, good biocompatibility and sustained release profile. Endocytosis studiesin vitrodemonstrated that the GA-NPs were effectively taken up by tumor cells in a time-dependent manner.In vivoreal-time imaging showed that the nanoparticles effectively accumulated within the tumor tissue after peritumoral administration. The cytotoxicity study revealed that the GA-NPs effectively inhibited the proliferation of gastric cancer cells. In vivoantitumor therapy with peritumoral injection of GA-NPs exhibited superior antitumor activity compared with free GA. Moreover, no toxicity was detected in any treatment group. Histological studies confirmed a lower cell density and a higher number of apoptotic cells in the GA-NPs group compared with the free GA group. Furthermore, the expression level of the cysteine proteases 3 precursor (pro-caspase3), a crucial component of cellular apoptotic pathways, was efficiently reduced in mice treated with GA-NPs. In conclusion, the GA-NPs system provided an efficient drug delivery platform for chemotherapy. [ABSTRACT FROM PUBLISHER]
- Abstract:
Copyright of Pharmaceutical Development & Technology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.